Centerline Biomedical Announces FDA Submission for IOPS System

글 내용 전체보기

BioSpace’s List of January 2019 Life Science IPOs

글 내용 전체보기

7 Out-of-the-Box Strategies to Advance Your Career

글 내용 전체보기

How to Explain a Resume Gap to a Potential New Employer

글 내용 전체보기

Civica Rx Starting With 20 Generic Drugs for Hospitals, Plans to Expand to 100+

글 내용 전체보기

FDA Might Have Plan to Continue Drug Approvals if Shutdown Continues

글 내용 전체보기

Unanimous Supreme Court Ruling Could Create Patent Problems for Small Pharma Companies

글 내용 전체보기

January 25 Research Roundup: Alzheimer’s Memory Recovery and Testing, New Antibiotics, Possible Stem Cell Therapy for Diabetes and More

글 내용 전체보기

AbbVie’s 2018: Revenues up, Earnings Down as Company Enters “Important New Phase”

글 내용 전체보기

BioSpace Movers and Shakers: Jan. 25

글 내용 전체보기

FDA Says New STS Patients Should Not Be Prescribed Lilly’s Lartruvo After Phase III Failure

글 내용 전체보기

As Brexit Looms, Novartis and Roche Stockpile Medicines in Case of No-Deal

글 내용 전체보기

Lilly’s tarnished Lartruvo faces uncertain future after FDA red-flags new patient starts

글 내용 전체보기

FiercePharmaAsia—Sun’s new headache; Takeda asset sale?; Chinese CAR-T player financing

글 내용 전체보기

$20B from Humira? We’re not there yet, and don’t count on it in 2019 either: AbbVie CEO

글 내용 전체보기

Novartis sounds alarm over what a hard Brexit will do to pharma, patients

글 내용 전체보기

Ingrezza-maker Neurocrine brings tardive dyskinesia awareness to the tube

글 내용 전체보기

Awareness is in: DTC disease campaigns surge in the U.S.

글 내용 전체보기

Vertex strikes deal with Merck KGaA to grow CRISPR/Cas9 toolkit

글 내용 전체보기

Chutes & Ladders—GSK chairman bows out as company prepares for split-up

글 내용 전체보기

U.K. calls for globally organized incentives for antibiotic R&D

글 내용 전체보기